August 6, 2018

Use of prescription opioids in U.S. remains high

By Karl Oestreich

by Linda Carroll

Use of prescription opioids remains high in the U.S., despite public health efforts and growing awareness of risks for abuse and overdose, a new study suggests. Over a decade, the proportion of adults being Reuters Logoprescribed opioid medications has changed little, but dosages have continued to rise and are especially high among patients with permanent disability, researchers report in The BMJ. That was surprising to study leader Molly Moore Jeffery of the Mayo Clinic in Rochester, Minnesota. “You expect to see them using more, but it was bigger than I expected,” she said. The dosages are concerning because they were higher than the “point where you see a greater risk of overdose,” Jeffery said.

Reach: Reuters offers 24-hour coverage of global happenings for professionals around the world. With 196 editorial bureaus in 130 countries and 2,400 editorial staff members, it covers international news, regional news, politics, social issues, health, business, sports and media.

Additional coverage: ABC News, Forbes, HealthDay, Daily Mail, Fierce Healthcare, KAAL, KIMT, KTTC

Context: Despite increased attention to opioidabuse, prescriptions have remained relatively unchanged for many U.S. patients, research led by Mayo Clinic finds. The research, published in The BMJ, shows that opioid prescription rates have remained flat for commercially insured patients over the past decade. Rates for some Medicare patients are leveling but remain above where they were 10 years ago. “Our data suggest not much has changed in prescription opioid use since about five years ago,” says Molly Jeffery, Ph.D., lead author, who is the scientific director of the Mayo Clinic Division of Emergency Medicine Research. More information about the study can be found on Mayo Clinic News Network.

Contact: Adam Harringa

Tags: Dr. Molly Jeffry, opioids, Reuters, Uncategorized

Contact Us · Privacy Policy